Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced Dyno-bn8, a novel adeno-associated virus ...
The inaugural Genetic Agency Technology Conference (GATC) gathered a group of researchers and entrepreneurs to discuss the vision for AI-based genetic medicine.
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced ...
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) and Dyno Therapeutics Inc. said that they have reach an agreement to develop next-generation adeno-associated virus or AAV vectors for gene therapy ...
This year's Amsoil/Mopar Muscle Engine Challenge featured Chrysler's low deck big-block with Edelbrock Performer RPM cylinder heads, which is a popular combination for both street and racing ...
The annual Amsoil/Mopar Muscle Engine Challenge is a favorite subject here at Mopar Muscle because it gives us a chance to share so much great information with our readers. Since this year's contest ...
Dyno’s AI-designed capsids improved therapeutic gene delivery to eye, muscle and CNS compared to commonly used AAV capsids, showcasing improved delivery efficiency, target-organ specificity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback